FDA Drug Application (020067) for EC-NAPROSYN by ATNAHS PHARMA US

Back to FDA Applications sponsored by ATNAHS PHARMA US

Application Number020067
Product Number002
FormTABLET, DELAYED RELEASE;ORAL
Dosage375MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameEC-NAPROSYN
Active IngredientNAPROXEN



Back to FDA Applications sponsored by ATNAHS PHARMA US

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.